Author

Tatiana Khariton

Observed names: T. Khariton, Tatiana Y. Khariton

Institution: Allergan (United States)

Observed institutions: Northwestern University, Shirley Ryan AbilityLab, University of California, Los Angeles, Allergan (United States), Methodist Rehabilitation, Forest Laboratories (United States)

OpenAlex ID: A5073608911

Penetration of Ceftaroline into the Epithelial Lining Fluid of Healthy Adult Subjects

2016 · Todd A. Riccobene, Richard Pushkin, et al. · Antimicrobial Agents and Chemotherapy · 52

Is a Thorough QTc Study Necessary? The Role of Modeling and Simulation in Evaluating the QTc Prolongation Potential of Drugs

2009 · Shashank Rohatagi, Timothy J. Carrothers, et al. · The Journal of Clinical Pharmacology · 44

Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community‐Acquired Bacterial Pneumonia

2016 · Todd A. Riccobene, Tatiana Khariton, et al. · The Journal of Clinical Pharmacology · 35

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Evaluate In Vitro Susceptibility Test Interpretive Criteria for Ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae

2013 · Scott A. Van Wart, Paul G. Ambrose, et al. · Antimicrobial Agents and Chemotherapy · 33

Population pharmacokinetics of ceftaroline in patients with acute bacterial skin and skin structure infections or community‐acquired bacterial pneumonia

2013 · Scott A. Van Wart, Alan Forrest, et al. · The Journal of Clinical Pharmacology · 33

Population Pharmacokinetics of Cariprazine and its Major Metabolites

2020 · Antonia Periclou, Luann Phillips, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 30

Pharmacokinetic-Pharmacodynamic Analysis for Efficacy of Ceftaroline Fosamil in Patients with Acute Bacterial Skin and Skin Structure Infections

2014 · Sujata M. Bhavnani, Jeffrey P. Hammel, et al. · Antimicrobial Agents and Chemotherapy · 27

Model‐Based Development of a PPARγ Agonist, Rivoglitazone, to Aid Dose Selection and Optimize Clinical Trial Designs

2008 · Shashank Rohatagi, Timothy J. Carrothers, et al. · The Journal of Clinical Pharmacology · 23

Evaluation of Population Pharmacokinetics and Exposure‐Response Relationship With Coadministration of Amlodipine Besylate and Olmesartan Medoxomil

2008 · Shashank Rohatagi, Timothy J. Carrothers, et al. · The Journal of Clinical Pharmacology · 22

Relationship Between Plasma Concentrations and Clinical Effects of Cariprazine in Patients With Schizophrenia or Bipolar Mania

2019 · Antonia Periclou, Susan Willavize, et al. · Clinical and Translational Science · 14

Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia

2013 · Sujata M. Bhavnani, Jeffrey P. Hammel, et al. · Antimicrobial Agents and Chemotherapy · 13

Population Pharmacokinetic Model for a Novel Oral Hypoglycemic Formed In Vivo: Comparing the Use of Active Metabolite Data Alone Versus Using Data of Upstream and Downstream Metabolites

2011 · Helen Kastrissios, Joseph R. Walker, et al. · The Journal of Clinical Pharmacology · 4

Poster Abstract #1: Clinically Meaningful Differences of the Ashworth Scale in Post-Stroke Upper Limb Spasticity

2008 · Amanda VanDenburgh, Manasee V. Shah, et al. · Neurotherapeutics · 2

1324. Target Attainment of Exebacase, a First-In-Class Antibacterial Lysin, to Determine Optimal Doses for Adult Patients with Staphylococcus aureus (S. aureus) Bloodstream Infections (Bacteremia) Including Endocarditis

2020 · Parviz Ghahramani, Tatiana Khariton, et al. · Open Forum Infectious Diseases

Poster 364: Consistent Efficacy of Botulinum Neurotoxin Type A: A Meta-Analysis From 7 Multicenter Studies of Upper Limb Spasticity in Post-Stroke Patients

2008 · Christina M. Marciniak, Susan Abu-Shakra, et al. · Archives of Physical Medicine and Rehabilitation

Poster 24: Ashworth Scale Score Changes From Baseline in Patients With Poststroke Upper-Limb Spasticity Treated With Botulinum Toxin Type A: Screening for Covariate Effects

2008 · Stuart Yablon, Amanda VanDenburgh, et al. · Archives of Physical Medicine and Rehabilitation

Clinically meaningful differences of the Ashworth Scale in patients with chronic post-stroke upper limb spasticity treated with botulinum neurotoxin type A (botox®)

2008 · Charles David, R. Zafonte, et al. · Toxicon

Works count: 17

Citation count: 332

H-index: 11

I10-index: 11